Both in Biotechnology
Curis vs Silexion Therapeutics
Over the past year CRIS returned −97.5% and SLXN returned −99.1%; their daily moves had a correlation of 0.01.
CRIS −97.5% SLXN −99.1%Growth of $1, one year, split-adjusted
| Metric | CRIS | SLXN |
|---|---|---|
| Price | $0.8290 | $0.3184 |
| Market cap | $2.0M | $1.8M |
| Today | −0.29% | +28.18% |
| 1 month | −44.4% | −12.2% |
| 6 months | −91.9% | −97.3% |
| Year to date | −95.8% | −98.3% |
| 1 year | −97.5% | −99.1% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | — |
| Net cash | $5.1M | — |
| Dividend yield | — | — |
| Volatility (60d) | 126.5% | 248.9% |
| Short % of float | 3.7% | 5.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).